Get started
Clorox (Extended hours)Clorox (Extended hours)Clorox (Extended hours)

Clorox (Extended hours)

No trades
See on Supercharts
Overview News
Ideas
Discussions Seasonals

CLX trade ideas

$CLX long-term buy! (4/5)Conviction: 4/5 Entry is not idea, could have better entry point if price goes down to retest support. Main thesis Bounced off long-term (1991) channel bottom in December Bounced off 50M-MAas well RSI-M also bounced off historical lows, although not levels with highest certainty Confirmed breakthrough from downward resistance line last week Touching lower bound of channel (2016) Misc Info P/S level of 3ish is high relative to historical levels, however much lower than some other tech companies... P/S level of 3 is about the same as S&P 500 Healthcare ( AMEX:XLV ) looks good compared to AMEX:SPY , could carry this up as well Potential Risks RSI-W is heating up, although does not preclude from uptrend in medium term (about a year) Just broke through (with confirmed close) last week from downtrend resistance line Quick ratio is deteriorating from mid 2021 General markets are very expensive, and we all know correlation goes to 1 in selloff. Revenue growth is negative ... likely as people become less sensitive to COVID?
NYSE:CLXLong
by asdf098
CLXOn the EMA chart 100,200,500,1000,2000 A very interesting situation, if it breaks out and holds the level, it may start to grow up. Despite the fact that we have already reached a significant correction to a strong level of 0.618 / 0.786 (according to various fibo reports), there is some divergence on the RSI. If the price breaks and holds 169 it might be interesting. At the same time, the picture is fundamentally different and the decline should continue. P / E = 48, it is super expensive, despite the fact that earlier it did not exceed 28, in fact it is 2 times overvalued. On the positive side for investors, Clorox will raise prices for a wider range of products than originally planned. The negative and the potential for decline is still displayed not only in the P / E estimate, but also a simple thing - the covid leaves and the need for detergents decreases, which is already shown in the report, which noted a drop in sales on an annualized basis. At the moment, there is pressure on the margin. An interesting two-year stack - comparing the results of the financial quarter of the 1st quarter of 2022 with the results of the financial quarter of the 1st quarter of 2020 in the second half of the pre-pandemic calendar of 2019 - shows a growth in revenue of 20.6%. It is interesting in any case how the paper will behave, whether there will be a technical rebound.
NYSE:CLX
by S0rt0
CLX, I smell bleach in the streets CLX from the weekly chart. CLX has been primarily trending up since the early 80’s. Near the end of Nov 2019 the 130 EMA was tested, and a rally was generated that broke the consolidations resistance line at that time. Stock prices soared around 65% in under a years’ time. Price has now fallen around 37%. I feel the price will retest the support line and enter an accumulation phase. My RSI and MACD-H are in completely oversold zone with the stochastic showing downward momentum. One thing I would like to note on the weekly is where the MACD-H lines are currently at. They have never been more oversold in the history of the stock. If the support line holds around $166.00, I will look for swing trades on the daily. If the price holds above the 130 on the weekly, I will increase position sizes.
NYSE:CLXLong
by jib232
Buy $CLX - NRPicks 21 MarThe Clorox Company manufactures and markets consumer products and professionals worldwide. It operates through four segments: Health and Welfare, Home, Lifestyle and International. For the past year, Clorox has been in the right market segment of the consumer industry at the right time: cleaning and disinfection products. In his latest earnings report he exceeded expectations with earnings per share of $2.03 and quarterly revenue of $1.84B Clorox's economic benefit has been trending higher over time, from about 10% a decade to 20% recently, implying that it becomes more effective in managing capital as it grows - Defensive - Dividend Yield 2.39% - Market Cap 23.20B - Sales Q/Q 27.10% Technical: - Low levels of RSI - Support $181 - Bounce in MA 100
NYSE:CLXLong
by NewroadTrader